Plaintiffs Exit Bayer MDL But Still Face Discovery

Law360, New York (December 1, 2010, 1:49 PM EST) -- A federal judge has allowed 10 of 15 named plaintiffs to drop their class action claims in multidistrict litigation alleging Bayer Corp. failed to obtain regulatory approvals for two aspirin drugs, on the condition the dismissed plaintiffs respond to Bayer's discovery requests.

Judge Brian M. Cogan of the U.S. District Court for the Eastern District of New York issued the order Nov. 24. Bayer said it was suspcious that the plaintiffs, who had not yet responded to discovery, sought to withdraw their claims just as they...
To view the full article, register now.